| 标题 |
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages |
| 网址 | |
| DOI |
10.1097/hep.0000000000001229
doi
|
| 其它 |
期刊:Hepatology 作者:Da-Long Yang; Lin Ye; Fan-Jian Zeng; Jie Liu; Hongbing Yao; et al 出版日期:2025-01-15 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)